Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain

被引：0
|
作者：
Rebeca Font
Josep Alfons Espinas
Agustí Barnadas
Angel Izquierdo
Jaume Galceran
Francina Saladie
Rafael Marcos-Gragera
Abigail Torrent
Paula Manchon-Walsh
Josep M. Borras
机构：
[1] Bellvitge Biomedical Research Institute (IDIBELL),Medical Oncology Department. Hospital Sant Pau
[2] Autonomous University of Barcelona,Epidemiology Unit and Girona Cancer Registry, Cancer Plan
[3] ICO,Tarragona Cancer Registry
[4] Foundation Society for Cancer Research and Prevention,School of Medicine
[5] IISPV,Department of Clinical Sciences
[6] University Rovira Virgili,undefined
[7] University of Girona (UdG),undefined
[8] University of Barcelona,undefined
[9] Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP),undefined
来源：
Breast Cancer Research and Treatment | 2019年 / 175卷
关键词：
Adherence; Breast cancer; Recurrence; Mortality; Population-based cancer registry; Adjuvant endocrine therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：733 / 740
页数：7
相关论文
共 50 条
  • [21] Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study
    Monteagudo, Monica
    Rodriguez-Blanco, Teresa
    Barrecheguren, Miriam
    Simonet, Pere
    Miravitlles, Marc
    RESPIRATORY MEDICINE, 2016, 121 : 26 - 31
  • [22] Adjuvant Chemotherapy is not Associated with Worse Disease-Free Survival in the Elderly Population.
    Mendes Gomes, L. B.
    Spina Donadio, M. D.
    Maciel Santana, D.
    Evangelista Simoes, M. F.
    Barbosa De Medeiros, M. F.
    De Andrade Souza, C. I.
    Petrocchi Corassa, M.
    De Freitas, H.
    De Lima, V. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S261 - S261
  • [23] End points for adjuvant therapy trials: Has the time come to accept disease-free survival as a surrogate end point for overall survival?
    Gill, Sharlene
    Sargent, Daniel
    ONCOLOGIST, 2006, 11 (06): : 624 - 629
  • [24] Aromatase Inhibitors As Adjuvant Therapy for Breast Cancer: Overall Survival Versus Disease-Free Survival As a Primary End Point in Clinical Practice
    Sanchez-Munoz, Alfonso
    Ribelles, Nuria
    Marquez, Antonia
    Perez-Ruiz, Elisabeth
    Alba, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) : E255 - E256
  • [25] Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival
    Juan J. Díez
    Emma Anda
    Victoria Alcazar
    María L. Isidro
    Cristina Familiar
    Miguel Paja
    Patricia Rojas Marcos
    Begoña Pérez-Corral
    Elena Navarro
    Ana R. Romero-Lluch
    Amelia Oleaga
    María J. Pamplona
    José C. Fernández-García
    Ana Megía
    Laura Manjón
    Cecilia Sánchez-Ragnarsson
    Pedro Iglesias
    Julia Sastre
    Endocrine, 2022, 77 : 121 - 133
  • [26] Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival
    Diez, Juan J.
    Anda, Emma
    Alcazar, Victoria
    Isidro, Maria L.
    Familiar, Cristina
    Paja, Miguel
    Rojas Marcos, Patricia
    Perez-Corral, Begona
    Navarro, Elena
    Romero-Lluch, Ana R.
    Oleaga, Amelia
    Pamplona, Maria J.
    Fernandez-Garcia, Jose C.
    Megia, Ana
    Manjon, Laura
    Sanchez-Ragnarsson, Cecilia
    Iglesias, Pedro
    Sastre, Julia
    ENDOCRINE, 2022, 77 (01) : 121 - 133
  • [27] A Population-Based Cohort Study of Overall Survival Following Curative-Intent Resection and Adjuvant Therapy for Pancreas Adenocarcinoma
    Vela, N.
    Kagedan, D.
    Bubis, L. D.
    Davis, L.
    Liu, Y.
    Mahar, A.
    Coburn, N.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S119 - S120
  • [28] Socioeconomic position and adherence to adjuvant endocrine therapy in premenopausal breast cancer patients-A Danish population-based cohort study
    Schmidt, Julie A.
    Woolpert, Kirsten M.
    Hjorth, Cathrine F.
    Farkas, Dora K.
    Ejlertsen, Bent
    Sorensen, Henrik Toft
    Cronin-Fenton, Deirdre P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 94 - 94
  • [29] Adjuvant therapy for node positive endometrial cancer: Overall survival and disease-free survival improved with combination chemotherapy and radiation for IIIC2 disease
    Maurer, K.
    Amarnath, S.
    Rose, P. G.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 173 - 175
  • [30] PATTERNS OF ADJUVANT ENDOCRINE THERAPY FOR EARLY BREAST CANCER IN ONTARIO: A POPULATION-BASED STUDY
    Madarnas, Y.
    Johnson, A.
    Jin, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 338 - 338
12345